Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC

Molecular and Cellular Biology

Volumn 31, Issue 24, 2011, Pages 5037-5045

  Zhang, Xiao Yong ^a   Pfeiffer, Harla K ^a   Mellert, Hestia S ^a   Stanek, Timothy J ^a   Sussman, Robyn T ^a   Kumari, Alpana ^a   Yu, Duonan ^b   Rigoutsos, Isidore ^c   Thomas Tikhonenko, Andrei ^b,f   Seidel, Hans E ^d   Chodosh, Lewis A ^d   Packham, Graham ^e   Baserga, Renato ^a   McMahon, Steven B ^a  

^a Department of Cancer Biology ^*  (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MYC PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE PROGRESSION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE TARGETING; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 83255188972     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/mcb.06297-11     Document Type: Article

References (44)

1. Allan, L. A., and M. Fried. 1999. p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene 18:5403-5412.
2. Arango, D., et al. 2003. c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. Br. J. Cancer 89:1757-1765.
3. Basso, K., et al. 2005. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37:382-390.
4. Batistatou, A., et al. 2006. Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours. J. Neurooncol. 77:17-23.
5. Bouchard, C., et al. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15:2042-2047.
6. Bush, A., et al. 1998. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev. 12:3797-3802.
7. Chen, X., et al. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106-1117.
8. Clemo, N. K., et al. 2008. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis 29:849-857.
9. Dang, C. V., et al. 2006. The c-Myc target gene network. Semin. Cancer Biol. 16:253-264.
10. D'Cruz, C. M., et al. 2001. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7:235-239.
11. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68.
12. Evan, G. I., et al. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
13. Fife, R. S., B. T. Rougraff, C. Proctor, and G. W. Sledge, Jr. 1997. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J. Lab. Clin. Med. 130:530-534.
14. Frank, S. R., M. Schroeder, P. Fernandez, S. Taubert, and B. Amati. 2001. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2069-2082.
15. Freie, B. W., and R. N. Eisenman. 2008. Ratcheting Myc. Cancer Cell 14:425-426.
16. Gehring, U. 2009. Multiple, but concerted cellular activities of the human protein Hap46/BAG-1M and isoforms. Int. J. Mol. Sci. 10:906-928.
17. Gotz, R., B. W. Kramer, G. Camarero, and U. R. Rapp. 2004. BAG-1 haplo-insufficiency impairs lung tumorigenesis. BMC Cancer 4:85.
18. Guccione, E., et al. 2006. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 8:764-770.
19. Gunther, E. J., et al. 2002. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 16:283-292.
20. Hummel, M., et al. 2006. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354:2419-2430.
21. Kingston, R. E., A. S. Baldwin, Jr., and P. A. Sharp. 1984. Regulation of heat shock protein 70 gene expression by c-myc. Nature 312:280-282.
22. Klapper, W., et al. 2008. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112: 1374-1381.
23. Kootstra, N. A., R. Matsumura, and I. M. Verma. 2003. Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Mol. Ther. 7:623-631.
24. Krajewska, M., B. C. Turner, A. Shabaik, S. Krajewski, and J. C. Reed. 2006. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers. Prostate 66:801-810.
25. Lowe, S. W., E. Cepero, and G. Evan. 2004. Intrinsic tumour suppression. Nature 432:307-315.
26. Maki, H. E., et al. 2007. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer. J. Pathol. 212:395-401.
27. McMahon, S. B., H. A. Van Buskirk, K. A. Dugan, T. D. Copeland, and M. D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
28. McMahon, S. B., M. A. Wood, and M. D. Cole. 2000. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20:556-562.
29. Murphy, D. J., et al. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457.
30. Park, Y. B., et al. 2002. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 133:105-111.
31. Patel, J. H., A. P. Loboda, M. K. Showe, L. C. Showe, and S. B. McMahon. 2004. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4:562-568.
32. Patel, J. H., and S. B. McMahon. 2007. BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J. Biol. Chem. 282: 5-13.
33. Patel, J. H., and S. B. McMahon. 2006. Targeting of MIZ-1 is essential for MYC mediated apoptosis. J. Biol. Chem. 281:3283-3289.
34. Popov, N., et al. 2007. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 9:765-774.
35. Rhodes, D. R., et al. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166-180.
36. Sarid, J., T. D. Halazonetis, W. Murphy, and P. Leder. 1987. Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc. Natl. Acad. Sci. U. S. A. 84:170-173.
37. Sharp, A., et al. 2009. Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions. J. Pharmacol. Exp. Ther. 331:680-689.
38. Soucek, L., et al. 2008. Modelling Myc inhibition as a cancer therapy. Nature 455:679-683.
39. Stone, J., et al. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
40. Sykes, S. M., et al. 2006. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24:841-851.
41. Townsend, P. A., A. Stephanou, G. Packham, and D. S. Latchman. 2005. BAG-1: a multi-functional pro-survival molecule. Int. J. Biochem. Cell Biol. 37:251-259.
42. Xiong, J., et al. 2003. Antisense BAG-1 sensitizes HeLa cells to apoptosis by multiple pathways. Biochem. Biophys. Res. Commun. 312:585-591.
43. Zhang, X. Y., L. M. Desalle, and S. B. McMahon. 2006. Identification of novel targets of MYC whose transcription requires the essential MbII domain. Cell Cycle 5:238-241.
44. Zhang, X. Y., et al. 2005. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 102:13968-13973.